|
|
8/16/21
|
Mainstay Medical, a Dublin, Ireland-based medical device company, has signed a 23.1k sf lease in the Little Italy neighborhood of Downtown San Diego. Mainstay Medical will become the first biotech firm to relocate to Downtown San Diego.
Mainstay Medical’s lease is at 2171 India St, part of a project featuring a mix of office, retail and dining tenants. The property sits just west of I-5 and is within walking distance of dozens of San Diego’s most popular dining, retail and entertainment destinations. Mainstay Medical plans to perform both office and light manufacturing out of this location.
Evan Knudson and Michael Peterson of CBRE represented the landlord, local real estate firm H.G. Fenton Company, in the transaction.
“This is a landmark deal for Downtown San Diego that builds on the momentum of recent large-scale investments in the life science space by IQHQ and Phase 3,” said Mr. Knudson. “Mainstay Medical’s new US headquarters in Little Italy was chosen for its European and urban feel, walkable amenities and close proximity to the airport and mass transit.”
Mr. Peterson added, “While San Diego County has long been known for the strength of its biotech and life science industries, these firms have never before entered the Downtown San Diego submarket. Mainstay Medical will be the first of many biotech firms to enjoy all of the amenities that Downtown and Little Italy have to offer.”
He added, “H.G. Fenton understood Mainstay’s vision and capitalized on the opportunity of this burgeoning product type. This is a fantastic outcome from a market-leading ownership group that has cultivated the growth of Little Italy. From the development of Piazza della Famiglia to this first-to-market biotech use, H.G. Fenton continues to add value to the vibrant Little Italy neighborhood.”
|
|
 Return to the Archive page
|
|
|
|
|
Printer-friendly Version
Email an Associate
